ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 103 filers reported holding ALLAKOS INC in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,782,760 | -47.9% | 2,988,000 | 0.0% | 0.74% | -17.4% |
| Q2 2023 | $13,027,680 | -28.9% | 2,988,000 | -27.5% | 0.90% | -29.3% |
| Q1 2023 | $18,334,596 | +52749.6% | 4,120,134 | 0.0% | 1.27% | -68.2% |
| Q4 2022 | $34,692 | -99.9% | 4,120,134 | 0.0% | 3.99% | +43.5% |
| Q3 2022 | $25,215,000 | – | 4,120,134 | – | 2.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 270,965 | $12,055,000 | 6.94% |
| NEA Management Company, LLC | 2,268,188 | $100,912,000 | 5.27% |
| Fairmount Funds Management LLC | 178,662 | $7,949,000 | 4.82% |
| Redmile Group, LLC | 2,976,928 | $132,444,000 | 3.71% |
| Boxer Capital, LLC | 675,000 | $30,031,000 | 2.05% |
| Rock Springs Capital Management LP | 235,000 | $10,455,000 | 0.43% |
| Cormorant Asset Management, LP | 200,000 | $8,898,000 | 0.41% |
| RAMIUS ADVISORS LLC | 31,155 | $1,386,000 | 0.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 15,700 | $692,000 | 0.32% |
| Handelsinvest Investeringsforvaltning | 20,000 | $890,000 | 0.24% |